Actinogen Medical Limited (FRA:3AC)

Actinogen Medical Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	16.5	9.45	8.46	16.37	13.46
Cash & Short-Term Investments	16.5	9.45	8.46	16.37	13.46
Cash Growth	74.63%	11.71%	-48.32%	21.65%	166.98%
Accounts Receivable	5.49	9.02	3.88	3.64	1.44
Other Receivables	0.31	0.29	0.24	0.3	0.11
Receivables	5.8	9.32	4.12	3.94	1.54
Prepaid Expenses	0.13	0.11	0.1	0.1	0.09
Total Current Assets	22.43	18.88	12.69	20.42	15.09
Property, Plant & Equipment	0.27	0.34	0.11	0.17	0.25
Other Intangible Assets	1.78	2.09	2.41	2.72	3.03
Total Assets	24.48	21.31	15.21	23.31	18.38
Accounts Payable	1.93	0.6	1.1	0.9	0.39
Accrued Expenses	0.96	0.7	0.61	0.5	0.29
Short-Term Debt	3.01	-	-	-	-
Current Portion of Leases	0.07	0.06	0.09	0.08	0.07
Total Current Liabilities	5.96	1.36	1.8	1.48	0.76
Long-Term Leases	0.19	0.26	-	0.09	0.17
Total Liabilities	6.15	1.62	1.8	1.57	0.92
Common Stock	122.28	106.04	83.65	81.88	64.16
Retained Earnings	-96.47	-81.74	-68.69	-57.94	-48.44
Comprehensive Income & Other	-7.47	-4.61	-1.55	-2.2	1.74
Shareholders' Equity	18.34	19.7	13.41	21.74	17.46
Total Liabilities & Equity	24.48	21.31	15.21	23.31	18.38
Total Debt	3.26	0.32	0.09	0.17	0.24
Net Cash (Debt)	13.24	9.13	8.37	16.21	13.22
Net Cash Growth	44.99%	9.06%	-48.33%	22.57%	184.27%
Net Cash Per Share	0.00	0.00	0.00	0.01	0.01
Filing Date Shares Outstanding	3,177	2,712	1,816	1,796	1,661
Total Common Shares Outstanding	3,177	2,683	1,816	1,796	1,661
Working Capital	16.47	17.52	10.89	18.94	14.34
Book Value Per Share	0.01	0.01	0.01	0.01	0.01
Tangible Book Value	16.55	17.6	11	19.02	14.42
Tangible Book Value Per Share	0.01	0.01	0.01	0.01	0.01
Machinery	0.11	0.08	0.07	0.03	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.